Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,079 INR | -0.09% | +5.16% | +26.39% |
04-25 | Glenmark Lifesciences' Net Profit Slides in Fiscal Q4 | MT |
04-01 | Glenmark Pharmaceuticals Limited Announces Board Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.39% | 3.65B | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals Unit Licenses Spanish Firm to Develop Autoimmune Diseases Antibody ISB 880